Search
for
Sort by
Research 331–360 of 1000+
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Multi-Approach Assessment of Albizia saponaria Bioactivity Against Dandruff-Related Bacteria and Fungi
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Development and Assessment of a Polyherbal Harsinghar (Nyctanthes arbortristis Linn.) Shampoo Efficacy Against Dandruff Compared to a Medicated Commercial Product
- Formulation and Assessment of polyherbal body lotion infused with Indigenous medicinal plants extracts
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Safety of dermatologic medications in pregnancy and lactation
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Bioavailability assessment of topical delivery systems: Effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- A Critical Assessment of the Evidence for Low-Level Laser Therapy in the Treatment of Hair Loss
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Clinical Assessment of Anti-inflammatory Activity of 940 Nanometer Low Level laser Therapy on Carrageenan Induced Arthritis in Temporomandibular Joint in Wistar Albino Rats
- Epidemiological Assessment of Testosterone Levels in Women Population: A Factorial Analysis of Cell Proliferation
- Safety and efficacy of microneedling with autologous platelet-rich plasma in chronic and stable alopecia areata
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Efficacy and safety of diode laser for facial hair reduction in hirsutism—a clinico-trichoscopic evaluation
- Light-emitting diode photobiomodulation in dermatology: From professional systems to consumer devices — mechanisms, efficacy and safety
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Noninvasive Assessment of Donor Area in Patients with Androgenetic Alopecia undergoing Hair Transplantation by Digital Imaging Technique
- Morphological characteristics and notes of the skin in preclinical toxicity assessment
- Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell–Conditioned Medium
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
- Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis